StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2023 - 12 - 08
1
2022 - 08 - 17
1
2021 - 09 - 23
1
2021 - 07 - 21
1
Sector
Health technology
4
Tags
Acute myeloid leukemia
1
Agreement
1
Alliances
1
Aml
1
Application
3
Approval
4
Biotech-beach
2
Biotechnology
4
Blood
6
Blue
5
Car-t
3
Cardio
1
Cardiovascular
1
Cel
8
Cell
8
Chmp
1
Clinical hold
3
Clinical-trials-phase-ii
3
Collaboration
1
Commercial
5
Commercialization
1
Companies
1
Conference
6
Decades
1
Device
1
Disease
13
Drug
2
Earnings
6
Events
10
Fda
13
Fda-approvals
4
Financial
11
Financial results
7
Gene therapies
12
Gene therapy
14
Genetown
20
Global
3
Health
2
Ipo
6
License
4
Market
7
N/a
38
Offering
3
People
10
Pharm-country
2
Phase 2
2
Positive
2
Presentation
2
Program
2
Report
3
Research
8
Results
18
Review
3
T-cell
3
Therapeutics
5
Therapy
32
Trial
2
Update
3
Year
2
Zynteglo
2
Entities
Biogen inc.
1
Bluebird bio, inc.
4
Bristol-myers squibb company
1
Novartis ag
1
Uniqure n.v.
1
Vericel corporation
1
Symbols
ABBV
37
ABT
25
ADCT
19
ADMA
17
AGIO
11
ALNY
13
AMGN
22
AMPH
9
AMRX
16
ANIP
17
ARGX
10
ARVL
14
ATLC
8
AVEO
20
BCRX
16
BGNE
25
BHC
8
BIIB
20
BMY
48
BPMC
23
BSX
8
CALT
8
CLVS
19
CNSP
11
EPZM
18
EXEL
14
FNCTF
21
FRG
15
GH
12
GILD
16
GSK
10
HALO
9
ILMN
12
IMAB
8
INCY
41
JAGX
8
JAZZ
8
JNJ
95
KMDA
11
KPTI
31
LLY
46
LTUM
11
MDT
28
MRK
8
NVAX
10
NVS
21
NVSEF
13
PFE
31
PRGO
22
REGN
32
RETA
9
RIGL
11
SNY
98
SNYNF
64
TAK
21
TEVJF
13
VRTX
8
VSTM
10
VTRS
8
YMAB
19
Exchanges
Nasdaq
4
Nyse
1
Crawled Date
2023 - 12 - 08
1
2022 - 08 - 17
1
2021 - 09 - 23
1
2021 - 07 - 21
1
Crawled Time
11:00
1
12:00
1
22:00
2
Source
www.biospace.com
3
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Approval
symbols :
BLUE
save search
bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Published:
2023-12-08
(Crawled : 22:00)
- biospace.com/
BLUE
|
$0.9229
-4.91%
-4.66%
7.9M
|
Health Technology
|
-80.87%
|
O:
6.03%
H:
8.43%
C:
-43.92%
fda
disease
approval
cell
bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions
Published:
2022-08-17
(Crawled : 22:00)
- biospace.com/
BLUE
|
$0.9229
-4.91%
-4.66%
7.9M
|
Health Technology
|
-86.02%
|
O:
-4.41%
H:
30.05%
C:
7.79%
zynteglo
fda
blood
approval
therapy
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published:
2021-09-23
(Crawled : 12:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
18.78%
|
O:
0.92%
H:
0.5%
C:
0.01%
BMY
|
$48.86
-0.27%
0.98%
14M
|
Health Technology
|
-18.77%
|
O:
0.42%
H:
1.55%
C:
0.38%
VCEL
|
$46.11
-0.67%
-0.72%
200K
|
Health Technology
|
-5.34%
|
O:
0.86%
H:
2.12%
C:
1.89%
QURE
|
$4.56
-4.0%
-3.94%
640K
|
Health Technology
|
-87.96%
|
O:
0.5%
H:
0.58%
C:
-5.62%
BLUE
|
$0.9229
-4.91%
-4.66%
7.9M
|
Health Technology
|
-94.89%
|
O:
1.11%
H:
2.8%
C:
2.53%
BIIB
|
$201.99
4.56%
4.32%
2.7M
|
Health Technology
|
-30.18%
|
O:
1.51%
H:
2.09%
C:
-0.17%
therapy
approval
bluebird bio Receives EC Approval for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor
Published:
2021-07-21
(Crawled : 11:00)
- biospace.com/
BLUE
|
$0.9229
-4.91%
-4.66%
7.9M
|
Health Technology
|
-96.63%
|
O:
0.7%
H:
1.6%
C:
-0.11%
gene therapy
therapy
approval
gene therapies
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.